2008 Summer Meeting
Are Quality Standards Possible in Antibiotic Resistance?
Track: Quality Standards
Program Code:128-L01
Date: 11 June 2008
Time: Wednesday, June 11, 2008
Location:603 - Level 6MEETING PLANNING ASSOCIATE:
Dr. Robert Rapp, PharmD, FCCP, Professor of Pharmacy, College of Pharmacy, University of Kentucky
| Robert P. Rapp, Pharm.D., FCCP, is Professor of Pharmacy in the College of Pharmacy and Professor of Surgery in the College of Medicine. Dr. Rapp also serves as Associate Director for Clinical Services in the Department of Pharmacy Services at the University of Kentucky Hospital. Dr. Rapp serves as a consultant to the Pharmaceutical Industry and is a member of the American Society of Microbiology, the Society of Infectious Disease Pharmacists, and American Society of Health-Systems Pharmacists, the American College of Clinical Pharmacy (charter member), and the Society for Healthcare Epidemiology of America. Dr. Rapp is also a Fellow of the American College of Clinical Pharmacy. He earned both his B.S. and Pharm. D. degrees at the University of Kentucky. During his academic career Dr. Rapp has published over 225 papers in the professional and scientific literature and has been the author on numerous text book chapters in infectious disease, sterile technology of parenteral drugs, and microbiology. He currently serves on the Editorial Board of the Annals of Pharmacotherapy, and as a reviewer for the American Journal of Health-System Pharmacy, Pharmacotherapy, Journal of the Joint Commission on Hospital Accreditation, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy American Journal of Health-System Pharmacists, and others. At the University of Kentucky College of Pharmacy Dr. Rapp teaches microbiology, sterile parenteral drug technology, infectious disease pharmacotherapy, and serves as the preceptor in infectious disease for both residents and students. |
MODERATOR:
Dr. Robert Rapp, PharmD, FCCP, Professor of Pharmacy, College of Pharmacy, University of Kentucky
| Robert P. Rapp, Pharm.D., FCCP, is Professor of Pharmacy in the College of Pharmacy and Professor of Surgery in the College of Medicine. Dr. Rapp also serves as Associate Director for Clinical Services in the Department of Pharmacy Services at the University of Kentucky Hospital. Dr. Rapp serves as a consultant to the Pharmaceutical Industry and is a member of the American Society of Microbiology, the Society of Infectious Disease Pharmacists, and American Society of Health-Systems Pharmacists, the American College of Clinical Pharmacy (charter member), and the Society for Healthcare Epidemiology of America. Dr. Rapp is also a Fellow of the American College of Clinical Pharmacy. He earned both his B.S. and Pharm. D. degrees at the University of Kentucky. During his academic career Dr. Rapp has published over 225 papers in the professional and scientific literature and has been the author on numerous text book chapters in infectious disease, sterile technology of parenteral drugs, and microbiology. He currently serves on the Editorial Board of the Annals of Pharmacotherapy, and as a reviewer for the American Journal of Health-System Pharmacy, Pharmacotherapy, Journal of the Joint Commission on Hospital Accreditation, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy American Journal of Health-System Pharmacists, and others. At the University of Kentucky College of Pharmacy Dr. Rapp teaches microbiology, sterile parenteral drug technology, infectious disease pharmacotherapy, and serves as the preceptor in infectious disease for both residents and students. |
PRESENTER(S):
Dr. Robert Rapp, PharmD, FCCP, Professor of Pharmacy, College of Pharmacy, University of Kentucky
| Robert P. Rapp, Pharm.D., FCCP, is Professor of Pharmacy in the College of Pharmacy and Professor of Surgery in the College of Medicine. Dr. Rapp also serves as Associate Director for Clinical Services in the Department of Pharmacy Services at the University of Kentucky Hospital. Dr. Rapp serves as a consultant to the Pharmaceutical Industry and is a member of the American Society of Microbiology, the Society of Infectious Disease Pharmacists, and American Society of Health-Systems Pharmacists, the American College of Clinical Pharmacy (charter member), and the Society for Healthcare Epidemiology of America. Dr. Rapp is also a Fellow of the American College of Clinical Pharmacy. He earned both his B.S. and Pharm. D. degrees at the University of Kentucky. During his academic career Dr. Rapp has published over 225 papers in the professional and scientific literature and has been the author on numerous text book chapters in infectious disease, sterile technology of parenteral drugs, and microbiology. He currently serves on the Editorial Board of the Annals of Pharmacotherapy, and as a reviewer for the American Journal of Health-System Pharmacy, Pharmacotherapy, Journal of the Joint Commission on Hospital Accreditation, Clinical Infectious Diseases, Journal of Antimicrobial Chemotherapy American Journal of Health-System Pharmacists, and others. At the University of Kentucky College of Pharmacy Dr. Rapp teaches microbiology, sterile parenteral drug technology, infectious disease pharmacotherapy, and serves as the preceptor in infectious disease for both residents and students. |
Dr. Craig Martin, PharmD, Clinical Pharmacy Specialist-Infectious Diseases, UK HealthCare, University of Kentucky
| Dr. Martin serves as the clinical pharmacist for University of Kentucky HealthCare's Antimicrobial Management Team. Dr. Martin is a recipient of ASHP’s “Best Practice Award” for 2004 as well as the Society of Infectious Diseases Pharmacists’ “Outstanding Clinical Practice in Infectious Diseases Pharmacotherapy” award for 2005. |
Description:
What quality standards will best help curb antimicrobial resistance in your institution? Discuss the issues with an expert and your fellow participants. Learn to identify appropriate infection control targets for hand hygiene and barrier precaution compliance, and discuss the potential goals for antimicrobial resistance rates in specific bacteria. Bring your own antibiogram or review one provided in the session. Discover new and effective ways to improve infection control procedures. Should the pharmacist serve on the infection control committee and if so, what should the pharmacist bring to the table. Discuss and define antimicrobial resistance/susceptibility rates for MRSA, VRE, ESBLs, ampC stable derepression, C. difficile associated disease, and carbapenem-resistance. Discuss and define the practice guidelines for antimicrobial stewardship. Learn to work with microbiology.
Learning Objectives:
- Identify appropriate infection control issues that require improvement.
- Define and discuss rates of antimicrobial-resistant Gram-positive and Gram-negative bacteria.
- Analyze your hospital antibiogram.
- Discuss the role of the infectious disease trained pharmacist on the antimicrobial stewardship team.
